NYSEARCA:LCTX

Lineage Cell Therapeutics Stock Predictions

etoro logo Buy LCTX
*Your capital is at risk
$1.20
-0.0100 (-0.83%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

LCTX Prediction Chart

LCTX Predictions History

Latest community submissions for LCTX.
Predictor Target Session Target Price Result Direction Accuracy Score
Mar 12, 2026 $1.72 +2.64% $1.58 X 90.87% 0
Mar 12, 2026 $1.71 +1.65% $1.58 X 91.92% 0
Mar 12, 2026 Bullish $1.58 X 0
Jul 31, 2025 $1.10 +6.80% $1.02 X 92.16% 0
Jul 30, 2025 Bullish $1.03 X 0
Jul 8, 2025 $0.93 -2.50% $0.98 X 94.08% 0
Jul 8, 2025 Bullish $0.98 X 1
Jul 7, 2025 $0.97 -3.79% $0.95 V 97.76% 1
Jul 7, 2025 $0.99 -2.37% $0.95 V 96.25% 1
Jul 7, 2025 $1.06 +4.95% $0.95 X 88.47% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for LCTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT LINEAGE CELL THERAPEUTICS, INC.
Lineage Cell Therapeutics
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-related macular degeneration; OPC1, an oligodendrocyte progenitor cell therapy that is in Phase I/IIa mul...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE